Annis Gardner Whiting Capital Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-13
Closed -$926 – 931
2026
Q1
$926 Hold
13
– – ﹤0.01% 1160
2025
Q4
$770 Buy
13
+8
+160% +$434 ﹤0.01% 1077
2025
Q3
$276 Hold
5
– – ﹤0.01% 1122
2025
Q2
$216 Buy
+5
New +$193 ﹤0.01% 1274
2025
Q1
– Sell
-5
Closed -$204 – 798
2024
Q4
$204 Buy
+5
New +$208 ﹤0.01% 765
2024
Q3
– Sell
-88
Closed -$3.85K – 875
2024
Q2
$3.85K Sell
88
-53
-38% -$2.56K ﹤0.01% 801
2024
Q1
$6.73K Buy
141
+43
+44% +$1.93K ﹤0.01% 720
2023
Q4
$4.63K Hold
98
– – ﹤0.01% 552
2023
Q3
$4.67K Buy
+98
New +$5.35K ﹤0.01% 538

Other funds holding NGVT

Annis Gardner Whiting Capital Advisors's NGVT Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Ingevity (NGVT) in Q2 2026, closing a stake of 13 shares — an estimated $926 sold.

Annis Gardner Whiting Capital Advisors first reported a position in NGVT in Q3 2023 and held it in 9 quarters. The position peaked at $6.73K in Q1 2024. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Ingevity position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 13 Ingevity shares in Q2 2026, an estimated $926.
  • Annis Gardner Whiting Capital Advisors first reported a position in Ingevity in Q3 2023 and held it in 9 quarters.
  • Annis Gardner Whiting Capital Advisors's Ingevity position peaked at $6.73K in Q1 2024.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.